Home/Filings/4/0001104659-21-051419
4//SEC Filing

Achenbach Brian 4

Accession 0001104659-21-051419

CIK 0001680048other

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 4:32 PM ET

Size

15.5 KB

Accession

0001104659-21-051419

Insider Transaction Report

Form 4
Period: 2019-12-06
Achenbach Brian
VP, Fin. & Corp. Controller
Transactions
  • Sale

    COMMON STOCK

    2020-10-21$2.97/sh3,056$9,076138,661 total
  • Sale

    COMMON STOCK

    2020-12-08$3.03/sh5,185$15,711133,476 total
  • Sale

    COMMON STOCK

    2019-12-06$3.69/sh6,144$22,671145,630 total
  • Sale

    COMMON STOCK

    2020-05-22$3.04/sh880$2,675141,717 total
  • Sale

    COMMON STOCK

    2021-04-09$3.36/sh2,423$8,141131,053 total
  • Sale

    COMMON STOCK

    2020-03-31$2.64/sh3,033$8,007142,597 total
Footnotes (8)
  • [F1]6,144 shares were sold in connection with the vesting of 13,750 shares on December 4, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F2]3,033 shares were sold in connection with the vesting of 8,750 shares on March 27, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F3]880 shares were sold in connection with the vesting of 3,438 shares on March 26, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F4]3,056 shares were sold in connection with the vesting of 9,063 shares on October 10, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F5]5,185 shares were sold in connection with the vesting of 13,750 shares on December 4, 2020, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F6]2,423 shares were sold in connection with the vesting of 8,750 shares on March 27, 2021, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Achenbach's tax withholding obligations. Mr. Achenbach had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  • [F7]Represents the weighted average sales price.
  • [F8]Includes restricted share units, which vest over various time periods.

Issuer

MUSTANG BIO, INC.

CIK 0001680048

Entity typeother

Related Parties

1
  • filerCIK 0001760132

Filing Metadata

Form type
4
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:32 PM ET
Size
15.5 KB